In conclusion, further research into PARP7 substrates and how their function is altered upon PARP7-mediated MARylation or its loss in malignancy could help create better strategies for targeting and treatment of cancers such as breast, ovarian, lung, pancreatic cancer and glioma. This evidence concerns the gene TIPARP and glioma.